Tuberculosis Screening and Testing of College and University Students

Works Cited for Frequently Asked Questions

Alexander, B. "Good Policies on Student Vaccination Can Inoculate Colleges Against Risk" The Chronicle of Higher Education, March 5, 2004.
Centers for Disease Control and Prevention. Testing & Diagnosis. Testing for TB Infection. May 2011.http://www.cdc.gov/tb/topic/testing/default.htm. Accessed December 2011.
Hennessey KA, Schulte JM, Cook L, Collins M, Onorato I, Valway SE. Tuberculin skin test screening practices among U.S. colleges and universities. JAMA 1998; 280(23):2008:12.
United States. Department of Homeland Security. Yearbook of Immigration Statistics: 2010. Washington, D.C.: U.S. Department of Homeland Security, Office of Immigration Statistics, 2011.
Braden CR. Infectiousness of a university student with laryngeal and cavitary tuberculosis. Clin Infect Dis 1995:21:565-70.
Colorado Department of Public Health and Environment. 2007 Guidelines for Tuberculosis Screening of College and University Students. http://www.cdphe.state.co.us/dc/tb/CollegeTBscreen.pdf. Accessed December 2011.
Miller, McNabb, Hisenrath, Pasipanodya, Drewyer, and Weiss. The Societal Cost of Tuberculosis: Tarrant County, Texas, 2002. AEP; 2010; 20 (1): 1-7.
Fleming R, Wolf J. Responding to MDR-TB Outbreak on Campus. ACHA Annual Meeting. Phoenix, AZ. June 1, 2011.
Centers for Disease Control and Prevention. Recommendations for Prevention and Control of TB Among Foreign-Persons: Report of the Working Group on TB Among Foreign-Persons. MMWR 1998;47(No. RR-16).
Centers for Disease Control and Prevention. Core curriculum on Tuberculosis: What the clinician should know. 5th ed. Atlanta, GA: US Department of Health and Human Services, CDC, 2011.http://www.cdc.gov/tb/education/corecurr/pdf/chapter1.pdf.
World Health Organization. Stop TB Partnership. Tuberculosis Country Profiles. 2011.http://www.stoptb.org/countries/tbdata.asp. Accessed December 20.2011.
Centers for Disease Control and Prevention. Updated guidelines for using interferon gamma release assays to detect mycobacterium tuberculosis infection. MMWR 2010;59(No. RR-5):1-28.
Centers for Disease Control and Prevention. Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings. MMWR 2005; 54 (No. RR-17):12.
Horsburgh C. & Rubin E. (2011). Latent tuberculosis infection in the United States. The New England Journal of Medicine, 3674(15), 1441-1448.
Sahni et al. Does the Implementation of an Interferon-γ Release Assay in Lieu of a Tuberculin Skin Test Increase Acceptance of Preventive Therapy for Latent Tuberculosis Among Healthcare Workers? Infection Control and Hospital Epidemiology , Vol. 30, No. 2 (February 2009), pp. 197-199.
Pai M, Zwerling A, Menzies D. T-Cell–based Assays for the Diagnosis of Latent Tuberculosis Infection Annals of Internal Medicine 2008;149:177-184.
Centers for Disease Control and Prevention. Core curriculum on Tuberculosis: What the clinician should know. 5th ed. Atlanta, GA: US Department of Health and Human Services, CDC, 2011. p. 82.
Canadian Tuberculosis Committee (CTC). Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS). Can Commun Dis Rep 2008; 34:1.
Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: A metaanalysis. Chest. 2010;137:952-968.
Ritz N, Yau C, Connell TG, Tebruegge M, Leslie D, Curtis N. Absence of interferon-gamma release assay conversion following tuberculin skin testing. Int J Tuberc Lung Dis. 2011;15:767-769.
Sauzullo I, Massetti AP, Mengoni F, Rossi R, et al. Influence of previous tuberculin skin test on serial IFN-gamma release assays. Tuberculosis. 2011;91:322-326.
Van Zyl-Smit RN, Zwerling A, Dheda K, Pai M. Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: A systematic review. PLoS ONE. 2009;4:e8517.
Heymann, D. Control of Communicable Diseases Manual, 19th edition. American Public Health Association, 2008, pp. 645 – 646.
Centers for Disease Control and Prevention. Questions and Answers About TB. June 2011.http://www.cdc.gov/tb/publications/faqs/qa_introduction.htm#Intro3 Accessed August 4, 2011.
Centers for Disease Control and Prevention. Questions and Answers About TB. Glossary. July 2010.http://www.cdc.gov/tb/publications/faqs/qa_glossary.htm. Accessed August 4, 2011.
Centers for Disease Control and Prevention. Questions and Answers About TB. Latent TB Infection. July 2010.http://www.cdc.gov/tb/publications/faqs/qa_latenttbinf.htm#Latent1 Accessed August 4, 2011.
Centers for Disease Control and Prevention. Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis. MMWR December 16, 2005 / 54(RR15);1-37.
Centers for Disease Control and Prevention. Latent Tuberculosis Infection: A Guide for Primary Health Care Providers, Appendix C. http://www.cdc.gov/tb/publications/LTBI/appendixC.htm. Accessed August 5, 2011.
Centers for Disease Control and Prevention. Latent Tuberculosis Infection: A Guide for Primary Health Care Providers.http://www.cdc.gov/tb/publications/LTBI/diagnosis.htm. Accessed August 5, 2011.
Centers for Disease Control and Prevention. Interferon-Gamma Release Assays (IGRAs) — Blood Tests for TB Infection. http://www.cdc.gov/tb/publications/factsheets/testing/IGRA.htm. Accessed December 20, 2011.
Centers for Disease Control and Prevention. Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005. MMWR 2005;54(No.RR-17):12, 81-83.
American Thoracic Society, CDC. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR 2000;49(No. RR-6).